Search results
-
Sound Pharmaceuticals, is a drug development company focused on developing drugs to treat hearing loss and brain injury. For more information please visit http://www.soundpharmaceuticals.com CONTACT: Dr. Jonathan Kil, President & CEO, Sound Pharmaceuticals, Inc., 4010 Stone Way N Suite 120, Seattle…
-
Latest Press Release: Immune Design Corp. Raises $32M in Series B Financing Immune Design Corp. (IDC) is a privately held biotechnology company based in Seattle, Washington and formed in 2008 to bring together some of the world’s leaders in the field of molecular immunology to develop therapeutic v…
-
Developer of a proprietary platform that yields biological therapeutic compositions of matter with a greater likelihood of success in clinical trials, particularly in autoimmune and inflammatory disorders.
-
PhaseRx is a startup company based in Seattle focused on the delivery of siRNA and other macromolecular therapeutics. The Company has attracted top-tier venture investors and was founded by its President, Robert Overell, Patrick Stayton and Allan Hoffman of the University of Washington, Oliver Pres…
-
Advice and Integration Services 515 Consulting Group provides a wide range of products and services to Pharmaceutical, Biotech and Medical Device companies throughout the world. Our advice and integration services include preparing for, selecting, implementing, validating and operating e-Regulatory…
-
HemaQuest Pharmaceuticals, Incorporated (“HemaQuest”) provides the materials on our web site for informational purposes only. Please read the following paragraphs. By using our web site, you agree to the terms described below. HemaQuest maintains this web site from our offices in Seattle, Washingto…
-
Eric D. Lynch, PhD President & Director Dr. Lynch completed his PhD at the University of California, Berkeley, where he mapped the first human gene for hearing loss, DFNA1 with Dr. Mary-Claire King. During his post-doctoral studies at the University of Washington, he cloned DFNA1 and DFNA15. He hel…